Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020 NDC 42794-016-10.
Published May 26, 2021 · Recall initiated: April 19, 2021
Summary
FDA records drug Class III recall D-0379-2021, published May 26, 2021 and initiated April 19, 2021. Recalling firm: SigmaPharm Laboratories LLC; Status: Terminated; Reported quantity: 6266 bottles; Lot: Lots # 2012501, 2012601 , 2012701, & 2100701, Exp. AUG 2022. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent
What to do
Voluntary: Firm initiated · Letter
Get an email if ASENAPINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ASENAPINE
- Manufacturer
- SigmaPharm Laboratories LLC
- Distributor
- Nationwide in the US
- UPC
- 0342794016103
- Lot
- Lots # 2012501, 2012601 , 2012701, & 2100701, Exp. AUG 2022
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHaloperidol Decanoate Injection, USP 100 mg/mL, 1 mL Single Dose Vials, Rx Only, Sterile, 10 Vials, TevaMay 26, 2021
- FDAPremierZen Black 5000, packaged in cardboard blisters containing one capsule per card, Distributed by YoloMay 26, 2021
- FDAMetoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial, Rx Only, TEVA Parenteral Medicines,May 26, 2021
- FDATriple SupremeZen Plus 3500, packaged in cardboard blisters containing one capsule per card, Distributed byMay 26, 2021
- FDAMethylprednisolone Acetate Injectable Suspension USP, 40 mg/mL, 10 mL Multiple Dose Vial, Rx Only, TevaMay 26, 2021
- FDASterile Water for Inj., USP, 25 x 100 mL Single Dose Vials per carton, Rx only, For Drug Diluent Use Only,May 26, 2021
Questions about this recall
Was Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020 NDC 42794-016-10. recalled?
Yes. FDA published recall D-0379-2021 on May 26, 2021. Reported hazard: Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ASENAPINE. UPC: 0342794016103.